
Jona offers a personalized microbiome test that analyzes an individual's gut microbiome using AI-powered insights from scientific research. The test identifies associations between microbiome composition and various health aspects such as GI health, skin, metabolic, and brain health, providing actionable recommendations for diet and lifestyle changes. Jona aims to help users address recurring symptoms, manage chronic conditions, and optimize overall health and performance. The company is backed by a team of microbiome experts, clinical experts, and longevity nutritionists, and its technology leverages AI to interpret complex microbiome data from scientific literature.

Jona offers a personalized microbiome test that analyzes an individual's gut microbiome using AI-powered insights from scientific research. The test identifies associations between microbiome composition and various health aspects such as GI health, skin, metabolic, and brain health, providing actionable recommendations for diet and lifestyle changes. Jona aims to help users address recurring symptoms, manage chronic conditions, and optimize overall health and performance. The company is backed by a team of microbiome experts, clinical experts, and longevity nutritionists, and its technology leverages AI to interpret complex microbiome data from scientific literature.
What they do: At-home gut microbiome sequencing with AI-driven, literature-linked personalized diet, supplement, and lifestyle recommendations
Founded: 2022
Headquarters: New York, US
Stage / funding: Seed (total funding reported ~$5M)
Founder / CEO: Leo Grady, PhD
Microbiome-driven personalized health and nutrition
2022
Biotechnology
Seed round reported with Meridian Street Capital and Breyer Capital as leads; Alumni Ventures listed among investors.
“Backed by investors including Meridian Street Capital, Breyer Capital, and Alumni Ventures”
| Company |
|---|